301 |
Risk factors: an introduction to the sociopsychological analysis of drug useNg, Yik-ying, Katherine., 吳奕瑩. January 2007 (has links)
published_or_final_version / abstract / Criminology / Master / Master of Social Sciences
|
302 |
A descriptive study of the perceived treatment and post-treatment environment for female ex-drug abusers in S.A.R.D.A.Soo, Kam-hing, Rosanna., 蘇錦馨. January 1988 (has links)
published_or_final_version / Social Work / Master / Master of Social Work
|
303 |
Current Topics in Prescription Drug Abuse and Misuse: Opportunities for AppNETHagemeier, Nicholas E. 28 February 2014 (has links)
No description available.
|
304 |
Prescription Drug Abuse Epidemiology and Prevention EffortsPack, Robert P., Loyd, S. 01 February 2014 (has links)
No description available.
|
305 |
Quaternary Prevention: Four States’ Approaches to Naloxone DisseminationDowling, Karilynn, Fleming, Marc, Melton, Sarah, Hagemeier, Nicholas E. 19 April 2017 (has links)
Naloxone has received increased public health attention in recent years given its effectiveness in the reversal of opioid overdoses. Despite continued increases in overdose death rates attributable to opioids, approaches to naloxone dissemination, prescribing and dispensing are quite variable across states. On the public health prevention continuum, naloxone dissemination and use could be considered quaternary prevention —actions taken to identify individuals at risk of over-medication, protect them from new medical invasion and suggest interventions which are ethically acceptable.
This presentation will describe approaches to overdose death prevention with naloxone in four states: Maine, Tennessee, Texas and Virginia. Particular emphasis will be placed on the role of community pharmacies in increasing naloxone dissemination. Attendees will be informed about recent legislative, educational and profession-specific prevention strategies and will thereafter engage in active learning to apply prevention strategies in their respective states. In addition to discussing barriers to and suggestions for increased naloxone uptake, presenters will describe assessments that can be used to evaluate overdose risk and subsequent naloxone co-prescribing/dispensing.
|
306 |
Prescription Drug Abuse: Past, Present and PreventionHagemeier, Nicholas E. 10 April 2015 (has links)
No description available.
|
307 |
Prescription Drug Abuse: Reflections and Visioning. First District Pharmacists Association – Tennessee Pharmacists AssociationHagemeier, Nicholas E. 27 March 2014 (has links)
No description available.
|
308 |
Prescription Drug Abuse: Reflections and VisioningHagemeier, Nicholas E. 06 November 2013 (has links)
No description available.
|
309 |
Prescription Drug Abuse: The Present Situation & Local Data and ServicesPack, Robert P., Hagaman, Angela, Loyd, S, Livesay, S, McAffrey, A. 02 November 2014 (has links)
No description available.
|
310 |
Family dependency treatment courts case studies from Mecklenburg County's families in recovery Staying Together (First) Program /Long, Amanda H. January 2009 (has links) (PDF)
Thesis (M.A.)--University of North Carolina Wilmington, 2009. / Title from PDF title page (February 16, 2010) Includes bibliographical references (p. 54-55)
|
Page generated in 0.0624 seconds